Dilip Madnani
Otolaryngology · New York, NYNPI 1225142896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 230 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Merz North America, Inc. accounts for 61.5% of it on its own, with 5 other manufacturers making up the rest. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $59.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$8K
- AbbVie$3K
- Revance Therapeutics, Inc.$2K
- Galderma Laboratories, L.p.$446
- Boston Scientific$40
- Apyx Medical Corporation$31
What the payments were for
- Food & beverage$13,602100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 54 | $8,364 |
| AbbVie(2 entities) | 118 | $2,835 |
| Revance Therapeutics, Inc. | 38 | $1,885 |
| Galderma Laboratories, L.p. | 18 | $446 |
| Boston Scientific | 1 | $40 |
| Apyx Medical Corporation | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$4,332
- BOTOX$278
- BOTOX COSMETIC$271
- DAXXIFY$264
How this compares
$13,602 in reported general payments places this provider in the 90th percentile of 701 otolaryngology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 16 | $699 |
| Ondansetron OdtOndansetron | 55 | $397 |
| Mupirocin | 54 | $286 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $233 |
| ErythromycinErythromycin Base | 26 | $228 |
| Acyclovir | 75 | $207 |
| Cephalexin | 53 | $205 |
| Azithromycin | 29 | $107 |
| Diazepam | 14 | $14 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in New York
- Roheen RaithathaNew York$830K
- Dennis KrausNew York$159K
- Anthony DelsignoreNew York$89K
- Satish GovindarajNew York$39K
- Lawrence LustigNew York$33K
- Justin GolubNew York$30K
- Brett MilesNew York$30K
- David HiltzikNew York$25K
- Milan AminNew York$23K
- Ashutosh KackerNew York$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.